Product

Company

NCT01682733·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Mayo Clinic

Age

18–50

Sex

ALL

Healthy volunteers

Not accepted

Diabetes
Unstable coronary artery disease
Heart failure
Cardiac arrhythmia
Cardiac valvular disease
Obstructive of interstitial lung disease
Females of child-bearing age \>18 or ≤ 50 who are pregnant or lactating
Mallampati score of 4
ASA 3 or above
Previous gastric surgery
Ulcer disease
Gastroparesis,
\> 5 cm Hiatal hernia
Congenital anomalies of the GI tract
Currently on or prescribed a medication known to affect weight within 3 months of study entry.

The record

StatusCompleted

PhasePhase 1

Taking part10

StartedAug 2012

UpdatedApr 7, 2015

Conditions

Where1

Clareo Health | Endoscopic Gastric Reduction for Weight Management